UnitedHealth Group Inc (UNH) Given Average Recommendation of “Buy” by Brokerages
Shares of UnitedHealth Group Inc (NYSE:UNH) have been assigned an average rating of “Buy” from the twenty-seven brokerages that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and twenty-four have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $223.82.
Several research analysts recently issued reports on the company. Jefferies Group restated a “buy” rating and set a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, December 1st. Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $219.00 to $246.00 and gave the stock an “outperform” rating in a research report on Friday, December 1st. Cantor Fitzgerald restated a “buy” rating and set a $235.00 price objective on shares of UnitedHealth Group in a research report on Monday, December 25th. Finally, ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th.
In other news, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at approximately $43,310,879.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Michele J. Hooper sold 5,000 shares of the company’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the sale, the director now owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 34,630 shares of company stock valued at $7,669,416. Insiders own 0.89% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the company. Blue Chip Partners Inc. purchased a new stake in UnitedHealth Group during the 2nd quarter worth $110,000. Kings Point Capital Management boosted its position in UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares during the period. Bruderman Asset Management LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth $121,000. Institutional investors and hedge funds own 86.01% of the company’s stock.
Shares of UnitedHealth Group (NYSE:UNH) traded down $2.31 during trading on Thursday, hitting $220.46. The company had a trading volume of 2,274,987 shares, compared to its average volume of 2,669,704. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group has a 1 year low of $156.09 and a 1 year high of $231.77. The firm has a market cap of $215,879.17, a P/E ratio of 24.44, a P/E/G ratio of 1.65 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the previous year, the firm posted $2.17 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group will post 9.99 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s payout ratio is 33.26%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.